InsiderTrades

Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2021-07-01 00:00:00 ET · period of report 2021-06-30 · accession 0001209191-21-044367 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-01 2021-06-30 AMRX BOYER ANDREW S EVP M - OptEx — +23.1K 162.8K +17% —
D 2021-07-01 2021-06-30 AMRX BOYER ANDREW S EVP F - Tax $5.12 -11.6K 151.3K -7% -$59.3K
D 2021-07-01 2021-06-30 AMRX BOYER ANDREW S EVP M - OptEx $0.00 -23.1K 46.2K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-06-30 M A 23,095 — 162,845 D — — (F1) Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Common Class A Common Stock 2021-06-30 F D 11,583 $5.12 151,262 D — — (F3) Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
3 Derivative Restricted Stock Units 2021-06-30 M D 23,095 $0.00 46,189 D — · — to — 23,095 Class A Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) On August 1, 2021, the reporting person was granted 69,284 restricted stock units vesting in three equal installments beginning on June 30, 2021.